NANOBIOTIX Closes $100M Global Offering, Extends Runway Through 2029
Nanobiotix completes €100M global offering, raising capital through share issuance and warrants. Proceeds allocated toward pipeline development and operations through 2029.
NBTXclinical-stageequity offering